NCT02039713终止不适用
Evaluation of Effectiveness and Safety of DESyne in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Seung-Jung Park20 个研究点 分布在 1 个国家目标入组 342 人开始时间: 2014年7月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 342
- 试验地点
- 20
- 主要终点
- Composite event rate
研究概览
简要总结
The purpose of this study is to evaluate effectiveness and safety of DESyne in Routine Clinical Practice
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 20 and more
- •Intervention with DeSyne drug eluting coronary stent
- •Agreed with written informed consent form
排除标准
- •Intervention with DeSyne drug eluting coronary stent and other drug eluting stent at the same time
- •Life expectancy of 1year and under
- •Cardiac shock
结局指标
主要结局
Composite event rate
时间窗: 1year
Death, non fatal myocardial infarction, Target Vessel Revascularization
次要结局
- All death(5year)
- Cardiac death(5year)
- Myocardial infarction(5year)
- Composite event of death or myocardial infarction(5year)
- Target Vessel revascularization(5year)
- Target Lesion revascularization(5year)
- Stent thrombosis(5year)
- Stroke(5year)
- Composite event of cardiac death or myocardial infarction(5year)
- Procedural success(3day)
研究者
Seung-Jung Park
MD,PhD
Asan Medical Center
研究点 (20)
Loading locations...
相似试验
招募中
不适用
IRIS- DESyne X2 in the IRIS-DES RegistryCoronary StenosisCoronary OcclusionCoronary DiseaseNCT03588481Seung-Jung Park1,000
进行中（未招募）
2 期
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery LesionsCoronary Artery DiseaseNCT05033964Elixir Medical Corporation200
招募中
不适用
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)Tricuspid Valve DiseaseTricuspid Valvular DisordersTricuspid RegurgitationNCT05848284VDyne, Inc.30
招募中
不适用
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid RegurgitationTricuspid Valve DiseaseTricuspid Valvular DisordersTricuspid RegurgitationNCT05797519VDyne, Inc.120
已完成
不适用
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye DiseaseDry Eye DiseaseNCT03492541Alcon Research134